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Abstract
Objective: Preparation of viable cultured adult cardiomyocytes (vARCs) is a prerequisite for cell-based transplantation and tissue
engineering. Ectopic gene expression is important in this context. Here, we present an in vitro cell replating strategy using Accutase for
cultured vARCs, allowing ectopic gene expression. Methods: Cultured vARCs from 6- to 8-week-old rats were used. Transfections with
EGFP (enhanced green fluorescent protein) constructs, Mlc-3f-EGFP or a-actinin-EGFP were performed using adenovirus-enhanced
transferrin-mediated infection (AVET). Accutase (PAA Laboratories, Linz, Austria) was used for the detachment of cultured cells.
Immunohistochemical analysis, together with confocal laser microscopy was used for structural analysis of the cells. Results: Cultured
vARCs could be detached with a high yield (40 to 60%) from primary cultures using Accutase. The cultivation period plays an
important role in the yield of viable cells. Resultant replated vARCs (rep-vARCs) rapidly (1–2 h) acquired a rounded up shape without
degradation of their contractile apparatus, which is in contrast to the rod-shaped freshly isolated vARCs (fi-vARCs). The detached cells
survived passage through a narrow syringe needle. After seeding, detached cells rapidly attached to various substrates, increased their
content of the contractile apparatus, and formed cell–cell contacts within 3 days after reseeding. The detached cells survived passage
through a narrow syringe needle. The high recovery of cells after replating enabled the use of the AVET system for gene delivery. AVET
is free of infectious particles and does not lead to expression of viral proteins. Transfection of vARCs prior to detachment had a small
effect on cell recovery and ectopically synthesized proteins were properly localized after replating. Conclusions: Detachment of cultured
vARCs using Accutase is well compatible with ectopic gene expression and yields a viable transgenic population of vARCs that
eventually may be suitable as transgenic cardiomyocyte grafts.
  2003 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
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1 . Introduction improved [3–7]. In long-term or redifferentiation culture,
vARCs first round up after isolation and undergo a
Cardiomyocyte cultures offer the possibility of perform- transient breakdown of the cytoskeleton, accompanied by
ing controlled in vitro studies on the pathogenesis of heart cessation of the beating activity. Later the cytoskeleton is
muscle. Cell cultures derived from embryonic and neonatal regenerated and beating activity is restored [8–13].
rat heart muscle have frequently been used for such Besides their availability for the analysis of basic
purposes [1]. Obviously, immature and mature car- aspects of morphogenesis, signaling and contractility [14–
diomyocytes in culture will differ considerably from one 16], vARC cultures represent an important basis for a
another. The physiology and ultrastructure of isolated adult possible use as transplants for damaged myocardium. The
cardiomyocytes in culture resemble more closely those of suitability of vARCs for the repair of myocardial defects
21
cardiomyocytes in the intact heart. Cultures of Ca - has been demonstrated [17]. However, success of graft
tolerant ventricular adult rat cardiomyocytes (vARCs) were formation seemed to be correlated to a rounded-up cellular
first described by Jacobson [2] and afterwards refined and morphology, which usually is only found in vitro for fetal
cardiomyocytes [18]. In long-term culture of vARCs
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rounded-up cells may be available after isolation and added to the medium. The investigation has been approved
before spreading. The use of stem-cell derived cells in by the Cantonal Committee for Animal Experimentation in
contrast is hampered by the need to remove undetermined Zurich and fully conforms with the 1996 NIH Guidelines
cells prior to injection in order to alleviate the risk of for Care and Use of Laboratory Animals.
teratoma formation [19].
Genetic engineering leading to a directed modification 2 .2. Accutase treatment
of the cellular metabolism of vARCs is more easily
accomplished in vitro than in vivo and has been proposed If not stated otherwise, primary cultures of vARCs were
as part of a transplantation strategy. Although adenovirus used after being kept for 9 days in culture. All incubation
has been widely used as transgene carrier in such experi- steps were performed in an incubator at 37 8C in a water
ments, primarily favored because of its high infection saturated atmosphere containing 5% CO . To improve the2
rates, there is nevertheless the disadvantage of a limited survival of the isolated cells during the replating procedure
persistence of ectopic gene expression [20], and more 5 mM butanedioxy-monoxim (BDM; Sigma) was added to
importantly, of the occurrence of inflammation and fibrosis all reagents, except for the preplating medium [21]. To
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around the tranplantation site. The potential risk arising improve detachment, serum and Ca were removed from
from the general exposure of the patient to infectious the culture and incubation and washing steps using M199
particle has led to the search for alternative systems. The (10 min) and phosphate-buffered saline (PBS) with EDTA
use of the AVET system (adenovirus-enhanced transferrin (0.5 mM) were employed for 10 min each. Two to three
infection), being free of infectious particles and not 15-min digestion steps with addition of fresh Accutase
involving expression of viral proteins, seemed to be a (PAA Laboratories) followed. After each digestion cells
valuable alternative to be used in conjunction with vARCs. were collected in ice-cold culture medium to quench the
However, so far vARCs, whether untransfected or trans- reaction and the cells were then kept on ice for complete
fected, could not be released in a viable state after termination of the digestion. Detached rounded-up cells
attachment and spreading on the substrate in vitro. This is were collected by centrifugation for 5 min at 703g at
a situation which would make it impossible to perform room temperature. To remove non-cardiomyocytes from
autologous cell transplantation or tissue repair, or to use the culture, cells were resuspended in culture medium
cardiomyocytes as host cells for in situ gene-based drug containing 1% FCS and preseeded in uncoated bacterial
delivery. culture dishes for 1 to 3 h at 37 8C in the incubator for
Here we present strategies using the AVET system in selective attachment of non-cardiomyocytes, e.g., fibro-
conjunction with the specific protease mixture Accutase. blasts. Subsequently, cells were centrifuged and collected
It allows the in vitro generation of tissue-injectable vARCs in culture medium, exactly as was done for the primary
transfected with desirable DNA constructs, yielding viable culture of freshly isolated cardiomyocytes.
adult cardiomyocytes released in vitro from the substrate in
a rounded-up state. Thus, vARCs can be used for various 2 .3. Gene transfer using the AVET system
purposes, among others especially for the transfer of
genetically engineered, possibly autologous, heart muscle Transfection of cardiomyocytes with the plasmids
cells into damaged myocardium. pEGFP-N3 (Clontech Laboratories, Palo Alto, CA, USA),
a-actinin-EGFP, or pMLC3f-EGFP [21] was performed by
using the AVET system, comprising transferrin–poly-
2 . Methods (L)lysine conjugates (Tf–pL) with an average chain length
of 250 lysine residues, streptavidin–polylysine conjugates
2 .1. Cardiomyocyte isolation and cultivation (STAV–pL) and biotinylated, psoralen-inactivated adeno-
virus (AdV) dl1014 [22,23]. Cultured vARCs were gener-
`Six- to 8-week-old female OFA rats (BRL, Fullinsdorf, ally transfected 6–8 days after the initial isolation pro-
Switzerland) were used for the isolation of vARCs. Cells cedure. In a typical experiment 3 mg STAV–pL in 100 ml
were isolated by retrograde perfusion of the hearts accord- HBS [150 mM NaCl, 10 mM 4-(2-hydroxyethyl)-1-
ing to an established method [9]. Culture dishes coated piperazine-ethanesulfonic acid (HEPES), pH 7.3] were
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with 0.1% gelatin were used throughout. After isolation mixed with 1.2310 biotinylated, inactivated AdVdl1014
cardiomyocytes were cultured in a medium containing in 100 ml HBS and incubated for 30 min at room
M199 (Animed, Basel, Switzerland), 10% fetal calf serum temperature. Addition of 3 mg of plasmid DNA in 150 ml
(FCS; PAA Laboratories, Linz, Austria), 20 mM creatine HBS was followed by a 30 min incubation step at room
monohydrate (Sigma, St. Louis, MO, USA), and 1% temperature. The mixture was combined with 3 mg Tf–pL
penicillin / streptomycin (Gibco, Grand Island, NY, USA). in 150 ml HBS and incubated for 30 min before the
To abolish growth of fibroblasts and other non-car- transfection mix was added dropwise to vARCs in 60-mm
diomyocyte cell types, 10 mM cytosine-arabinoside (araC; cultures dishes; the dishes were then centrifuged for 5 min
ICN Biochemicals, Cleveland, OH, USA) was routinely at 1003g to allow rapid aggregation of the transfection
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complexes on the cell surface. 4–16 h after the transfection coupled donkey anti-mouse IgG (Jackson Immuno Re-
the cultivation medium was replaced. search). Immunohistochemistry was analyzed using a Zeiss
Axiophot fluorescence microscope equipped with Neofluor
2 .4. Immunohistochemistry objectives (Zeiss, Feldbach, Switzerland). Alternatively, a
Leica true confocal scanner TCS NT on the inverted
Cells were fixed in 3% paraformaldehyde in PBS, pH microscope Leica DMIRB-E (Leica, Mannheim, Germany)
7.4 for 15 min, washed with PBS, and permeabilized with was used.
0.2% Triton X-100 in PBS for 12 min. To minimize
non-specific binding, cells were incubated with 0.1%
bovine serum albumin in PBS for 20 min. A monoclonal 3 . Results
mouse anti-myomesin antibody (clone B4; generated in
this laboratory) [24] was used as sarcomeric M-line 3 .1. Detachment of ventricular adult rat cardiomyocytes
marker. A polyclonal rabbit anti-cadherin antibody
(Sigma–Aldrich) was used to visualize intercalated disc Accutase treatment allowed detachment and survival
structures. F-actin was stained with rhodamine-conjugated of a 9-day spread out primary long-term culture of vARCs
3phalloidin (Molecular Probes, Eugene, OR, USA). The from a culture dish containing about 3.0310 cells per
cells were incubated with the primary antibodies for 2–3 h 30-mm dish. Fig. 1 shows the time–course of the detach-
at room temperature, thoroughly rinsed three times with ment by employing time-laps video microscopy. Within
PBS and incubated with secondary antibodies for 1 h. minutes after Accutase treatment the filopodia of the
Combinations of fluorescein isothiocyanate (FITC), Cy-3 cells became stunted, cell–cell contacts were disrupted,
and Cy-5-conjugated secondary antibodies were used. and rounding-up of the cells became evident. Accutase
Cadherin was stained by FITC-conjugated goat-anti-rabbit treatment allowed the removal of almost all vARCs from
IgG (Cappel Research, Hamburg, Germany), myomesin the culture dishes, but it was obvious that the in vitro
was detected by FITC-conjugated goat anti-mouse IgG redifferentiation time period of the initial vARC culture
(Jackson Immuno Research, Hamburg, Germany), or Cy5- critically affected the yield of replated vARCs (rep-
 
Fig. 1. Live 9-day vARC culture during treatment with Accutase. Video time-laps records at indicated time points of treatment.
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Fig. 2. The yield of rep-vARCs after treatment with Accutase is dependent on the pretreatment time (days) in culture. The yield is expressed as ratio of
the cell numbers for vARCs on corresponding dishes prior to the treatment, compared to cell numbers for rep-vARCs 3 days after re-plating as determined
by immunohistochemical detection of myomesin. Data shown were means6S.E.M. of at least three independent experiments.
vARCs) if observed 3 days after re-plating (Fig. 2). A cadherin signal in fi-vARCs was restricted to the former
pronounced peak of replating efficiency after Accutase intercalated disc (Fig. 3a, arrow), cadherin was found
was observed between 9 and 15 days after the initial highly dispersed over the cell surface of the detached
plating of the vARCs. Nine-day cultures of vARCs fre- vARCs indicating an altered distribution of the protein
quently showed some non-cardiomyocyte cells which, (Fig. 3b). Beating activity, however, could be observed in
however, clearly were preferably released from the sub- a large fraction of the replated cells from detachment
strate at an early stage after Accutase treatment. After throughout the entire observation period definitely being in
separation of the non-cardiomyocyte cells, the remaining contrast to fi-vARCs, which resumed beating only after
fractions represented about 85% of all vARCs recovered. about a week in culture and after spreading on the
If rep-vARCs were subjected after 9 days after replating substrate.
to an additional round of Accutase treatment, and a There was a clear time-line difference concerning
second detachment had taken place, again a good recovery reformation and spreading of rep-vARCs compared to the
of viable, beating cells could be observed, evidently also initial vARCs, thus pointing to rather altered characteris-
providing a means to prolong the life-span of the vARCs tics of the behavioral pattern. Very briefly after reseeding
in vitro. the Accutase treated cells attached to the substrate,
spread out and seeked contact with neighboring cells.
3 .2. Cellular behaviour of vARCs after detachment and Reformation of new myofibrillar structures started already
replating 1 day after replating (Fig. 3e). This was in contrast to the
redifferentiation behaviour of fi-vARCs. At day 1 after
Whereas freshly isolated vARCs (fi-vARCs) obtained replating fi-vARCs were losing the rod-shaped morphology
after isolation of cardiomyocytes from adult tissue dis- (Fig. 3d) and at day 3 the rounded-up cells had lost most
played a rod-shaped morphology with regularly aligned of the sarcomeric structures (Fig. 3g). Whereas vARCs
myofibrils, the enzymatic release of polymorphic, spread- after 5 days in culture just started to spread out and to form
out vARCs from the culture dish resulted in a suspension myofibrils (Fig. 3k), rep-vARCs spread out right after
of mainly rounded-up vARCs (Fig. 3a–c). While the plating and established new intercalated-disk-like struc-
Fig. 3. Comparison of the redifferentiation process of freshly isolated vARCs (a, d, g, k) and of 9-day-old vARCs after Accutase treatment and replating
(b, c, e, f, h, j, l, m). Immunohistochemical analysis of cadherin (green) in intercalated disc-like structures, and of myomesin (red) indicating M-lines of
myofibrillar sarcomeres. Representative cells are shown directly after isolation from heart tissue (fi-vARCs) (a) or after Accutase treatment of a 9-day-old
vARC culture (b, c); untreated vARCs at 1 day (d), 3 days (g), 5 days (k) after plating; after Accutase treatment at 1 day (e, f), 3 days (h, j), 5 days (l, m)
after re-plating. Video time-laps live records (c, f, j, m). Arrows indicate perinuclear localized myofibrils in spread-out cardiomyocytes after Accutase
treatment. Note different scale bars in k and l.
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tures as represented by cadherin expression and localiza- distribution of ectopically expressed fusion protein a-
tion, thereby allowing new functional interactions and actinin-EGFP was analyzed in relation to f-actin stressfib-
coordinated beating activity already 1 day after replating ers (Fig. 5d) in spread-out rep-vARCs. Five days after
(Fig. 3e, h, l). Live-shots of rep-vARCs shown in Fig. 3c, replating; a-actinin was correctly integrated into the Z-line
f, j, m demonstrate, that already at day 3 after replating of myofibrillar sarcomers and correlated well with the
spread-out cells closely resembled vARCs after 9 and more myofibrillar scaffold formed by f-actin in a more or less
days in culture. perinuclear fashion as had been reported earlier [10]. It
The detached rounded-up vARCs survived passage was evident that detachment, rounding-up and replating of
through a syringe needle much better than fi-vARCs. This vARCs did not deteriorate expression and proper localiza-
is a precondition for transplantation of donor cells into tion of fusion proteins in previously transfected vARCs.
infarcted myocardium. It would allow one to transfer This was additionally demonstrated by transfection of
vARCs in a state of enhanced and fast redifferentiation 9-day-old vARCs with a construct encoding for Mlc-3f-
competence. As shown in Fig. 4 recovery of fi-vARCs EGFP fusion protein. Recovery of previously transfected
above 2.0 ml /min was significantly diminished, while cells after replating was not significantly lowered if
survival of Accutase treated vARCs remained mainly compared to EGFP alone (Fig. 6)
unaffected even at high flow rates.
3 .3. Ectopic gene expression in rep-vARC 4 . Discussion
The AVET system was used to transfect 9-day-old Several attempts have been made to generate transplant-
vARCs with vectors encoding EGFP alone (Fig. 5a, c) or able cardiac muscle cells to substitute for loss of cardiac
as fusion protein with -actinin (Fig. 5b, d). The morpholo- function. Recently, stem cells as a source of car-
gy and sarcomeric organization of transfected and detached diomyocytes for transplantation became of interest [25],
cells were analyzed 5 days after replating. Fig. 5a shows but also several problems like rejection of the transfered
expression of EGFP in one of two neighboring cells. cells, the risk of, e.g., teratoma formation arising from the
Neither an apparent effect on cell shape nor on the use of undifferentiated, but also ethical issues remain to
organization of the sarcomers, which were immunostained date unresolved. Evidence, however, is rising, that trans-
for the M-band protein myomesin, was observed. Overlay planted cells may have a pronounced potential to locally
of the red myomesin signal on top of the green intracellu- deliver growth factors [26] and that the use of genetically
lar signal of ectopically expressed EGFP resulted in a engineered adult cardiomyocytes for in-situ drug delivery
yellow sarcomeric striation (Fig. 5c). The myofibrillar would be appealing. The proper targeting to the site of
action followed by electrical and mechanical coupling of
the implanted vARCs [27], a high specific metabolic
 potential [28], and a possible life-time survival in the adult
heart, render vARCs particularly suitable host cells. Pa-
tient-derived non-dividing adult cardiomyocytes could
render such a transplantation approach safe as far as
immunological and tumorigenic risks are concerned [29].
In the present study, a strategy for the transfer of ge-
netically engineered adult ventricular cardiomyocytes of
rats is shown and data are presented which support the
feasibility of such an approach.
Although, in vitro cultures of adult cardiomyocytes have
already been performed in this laboratory for quite some
time [9,30–32], and a wealth of methods and instru-
mentation has been established in vitro [15,33], studies of
adult cardiomyocytes were limited to cells attached to
substrate in rather short-lived primary cultures. Neverthe-
less, this allowed gene transfer and control of gene
expression [34,35] and one could gain insight into various
Fig. 4. Nine-day-old vARCs detached by Accutase (circles) survive cellular processes in real-time in vitro, e.g., the formation
passage through a syringe needle much better than fi-vARCs (squares). of cell–cell contacts or of sarcomeric structures [15,16]
Survival is expressed as fraction of surviving fi-vARCs and surviving demonstrating the redifferentiation capacity of cultured
detached 9-day-old vARCs before and after passage through a 0.2 mm
vARCs. Cell transfer, however, of fi-vARCs into diseasedinner diameter needle at volumetric flow-rates indicated. Immunohistoch-
myocard turned out to be problematic, because injectionemical detection of myomesin was performed 3 days after plating or
replating. was not easy to perform without loosing the cells [36].
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Fig. 5. Transfected vARCs synthesize and correctly target ectopically expressed proteins after Accutase treatment and replating. Cells were transfected
with expression vectors encoding EGFP (a, c) or an a-actinin-EGFP fusion protein (b, d) 5 days prior to replating. EGFP signals are green in (c, d),
myomesin is red in (c) and f-actin is red in (d). Superposition green/ red is yellow. Corresponding expression cassettes are shown.
Neonatal cardiomyocytes had been successfully injected important advantage for cell transplantation and for forma-
into cardiac tissue, indicating the feasibility of using tion of grafts. Consequently, a rapid functional integration
cardiomyocytes for this purpose [37], but show on the of transplanted cells into existing cardiac structures and a
other hand only a minor differentiation capacity. The here high yield of surviving cells at the injection site could be
reported treatment of cultured adult rat cardiomyocytes, expected. Indeed, as had been reported earlier the suitabili-
vARCs, with Accutase led to the formation of viable, ty of neonatal and fetal cardiomyocytes is correlated with
rounded-up cells, what was quite in contrast to prior this characteristic [18]. Transplantation of genetically
attempts to detach viable adult cultured cardiomyocytes by engineered vARCs will much depend on the availability of
the use of trypsin or other reagents. viable detached cardiomyocytes. Therefore, it was im-
Thus, several goals could be achieved. Rounded-up, portant that we could show that also transfected vARCs
highly differentiated adult cardiomyocytes allowing the could be detached by Accutase and viably replated
passage through narrow needles required for injection, without loss of the transfected transgenes. Expression of
could be produced. We have also found that the detached ectopic proteins was not impaired by the detachment.
and replated transgenic adult cardiomyocytes show rapid Transfection of EGFP alone was somewhat better than
spreading and a high, 40 to 60%, recovery in viable cells. transfection of the Mlc-3f-EGFP fusion protein, which is
Multiple rounds of detachment by Accutase resulted in a an observation being made for other cell types as well.
similar recovery of viable cells thus providing an addition- However, during replating of Mlc-3f-EGFP transfected
al means to prolong the life-span of vARCs in culture. cells and untransfected cells were equally well transferred.
The observed rapid formation of new cell–cell contacts In the context of a possible gene therapy the above
and the extended formation of myofibrils might be an mentioned characteristics are important.
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